Molecules 2008, 13(4), 892-903; doi:10.3390/molecules13040892
Article

Cytoprotective Efficacy of Amifostine Against Radiation- Induced Rectal Toxicity: Objective and Subjective Grading Scales for Radiomucositis

1 Kapodistrian University, 2nd Radiology Department, Medical School, Attikon University Hospital, Rimini 1, Xaidari, Greece 2 Aretaieion University Hospital, 1st Radiology Department, Radiotherapy Unit, Athens, Greece.
* Author to whom correspondence should be addressed.
Received: 1 February 2008; in revised form: 16 April 2008 / Accepted: 16 April 2007 / Published: 18 April 2008
(This article belongs to the Special Issue Prodrugs)
PDF Full-text Download PDF Full-Text [103 KB, uploaded 1 October 2008 09:18 CEST]
Abstract: Curative radiation therapy of pelvic malignancies, frequently results in doselimitingtoxicities such as serous, mucoid, or more rarely, bloody diarrhea. Several studieshave evaluated the cytoprotective effects of amifostine in preventing rectal mucositisassociated with radiation treatment. We searched Medline for published comparativestudies that evaluated the use of amifostine to reduce radiation-induced toxicity associatedwith pelvic irradiation. In ten studies there was an evidence-based cytoprotection (P less than 0.05)by amifostine. Although results are variable, current evidence suggests that amifostine mayhave a radioprotective effect in the rectal mucosa, particularly when administeredintrarectally. Significant improvements were seen in both symptomatic and objective(rectosigmoidoscopy) end points. There is a need to conduct well-designed clinical trialswith sufficient numbers of participants to confirm these findings together with a costbenefitstudy. Objective measurements using rectosigmoidoscopy are superior tosubjective measures such as WHO or RTOG/EORTC toxicity grading scales.
Keywords: Cytoprotection; radiotherapy; rectum; mucositis; toxicity; amifostine.

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Kouloulias, V.E.; Kouvaris, J.R. Cytoprotective Efficacy of Amifostine Against Radiation- Induced Rectal Toxicity: Objective and Subjective Grading Scales for Radiomucositis. Molecules 2008, 13, 892-903.

AMA Style

Kouloulias VE, Kouvaris JR. Cytoprotective Efficacy of Amifostine Against Radiation- Induced Rectal Toxicity: Objective and Subjective Grading Scales for Radiomucositis. Molecules. 2008; 13(4):892-903.

Chicago/Turabian Style

Kouloulias, Vassilis E.; Kouvaris, John R. 2008. "Cytoprotective Efficacy of Amifostine Against Radiation- Induced Rectal Toxicity: Objective and Subjective Grading Scales for Radiomucositis." Molecules 13, no. 4: 892-903.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert